Profile avatar
valenceai.bsky.social
Industrializing scientific discovery to radically improve lives. Powered by @recursionpharma.bsky.social
38 posts 340 followers 2 following
Regular Contributor
Active Commenter
Posts 12 Comments 27

Advancing our vision for a virtual cell: In a presentation at #JPM2025, CEO Chris Gibson shared his vision for #TechBio, in which biol & chem datasets & highly predictive ML models, including advanced protein folding, will allow us to build a true virtual cell. ir.recursion.com/static-files...

submitted 43 days ago • 0 comments

The Valence team was proud to share our research at NeurIPS last week. We had 14 papers across the main conference and workshops. At the Foundation Models for Science workshop, Valence and @recursionpharma.bsky.social researchers won first, second, and third place 🧵

submitted 67 days ago • 1 comment

Valence scientist Michael Craig will serve as the Senior Chair for the Drug Discovery and Development roundtable at the ML4H conference today. This session will focus on the role of LLMs and foundation models in accelerating drug discovery. Learn more: ahli.cc/ml4h/researc...

submitted 71 days ago • 0 comments

Thank you to everyone who attended our event at #NeurIPS2024 with @RecursionPharma and @nvidia earlier this week. We're presenting multiple posters at the workshops today. Talk to us and learn more about our open roles. We're hiring: www.valencelabs.com/careers Workshop schedule👇

submitted 72 days ago • 1 comment

Generative models often create molecules that are hard to synthesize. Tomorrow, we present SynFlowNet, a GFlowNet designed to generate synthesizable molecules using documented reactions and purchasable materials. Learn more at the MLSB workshop: arxiv.org/abs/2405.01155

submitted 73 days ago • 0 comments

🧵 At NeurIPS last year, we introduced Sequential Attachment-based Fragment Embeddings (SAFE), a novel line notation for chemical structures that reimagines SMILES strings as an unordered sequence of interconnected fragment blocks. youtu.be/oJsj5vWmD3c

submitted 74 days ago • 1 comment

Missed the event yesterday? Our team is still at NeurIPS today and throughout the workshops. Come talk to us and learn more about open roles. We’re hiring for both full-time and internship positions: www.valencelabs.com/careers

submitted 74 days ago • 0 comments

Tonight is our TechBio social with @recursionpharma.bsky.social and NVIDIA. Meet fellow scientists, engineers, and founders working at the intersection of ML and drug discovery at Science World. Space is limited. Join the waitlist: lu.ma/biikt7ox

submitted 75 days ago • 0 comments

Multimodal techniques rely on paired samples to learn common representations, but these samples are hard to collect in biology where measurement devices often destroy samples. How do we enable a multimodal future in TechBio? Learn more today at NeurIPS. youtu.be/7a29mGz9LXI

submitted 75 days ago • 0 comments

MolPhenix is a foundation model that can predict the effect of any given molecule and concentration pair on phenotypic cell assays and cell morphology. We'll be presenting this work at NeurIPS next week. Come chat with us! Paper: arxiv.org/pdf/2409.08302

submitted 83 days ago • 0 comments

Valence Labs will be co-hosting a TechBio social with @recursionpharma.bsky.social and NVIDIA at #NeurIPS in Vancouver. Join us on Thurs, Dec 12th. RSVP here: lu.ma/biikt7ox Our team will also be at NeurIPS throughout the week. See below for a summary of our papers👇

submitted 90 days ago • 1 comment

We curated 40+ quantum mechanics datasets, covering 250+ quantum methods & 1.5B geometries. All of this is easily accessible through the OpenQDC library. 🧵 Harness the power of QM data with a single line of code: www.openqdc.io Read the blog: www.valencelabs.com/blog-posts/o...

submitted 91 days ago • 1 comment